Holper et al., 1960 - Google Patents
Further studies on multiplication, serology and antigenicity of 2060 and JH virusesHolper et al., 1960
- Document ID
- 2897000233395136453
- Author
- Holper J
- Miller L
- Crawford Y
- Sylvester J
- Marquis G
- Publication year
- Publication venue
- The Journal of Infectious Diseases
External Links
Snippet
METHODS Virus.? Cultures of 2060 and JH virus were obtained from Dr. WJ Mogabgab of Tulane University. The agents have been passed only in moneky kidney cells. The virus was stored in the form of infected monkey kidney tissue culture fluid in sealed tubes at? 60 C until …
- 241000700605 Viruses 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
- Y10S435/822—Micro-organisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from micro-organisms
- Y10S530/825—Bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barnard | Rift Valley fever vaccine-antibody and immune response in cattle to a live and an inactivated vaccine | |
| Miyamura et al. | Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells: II. Comparison with the rabbit skin method and practical application for sero-epidemiological studies | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Gaines et al. | Prevalence of antibody to Pseudomonas in normal human sera | |
| Davies et al. | A new bluetongue virus serotype isolated in Kenya | |
| Hayward | Serological studies with herpes simplex virus | |
| Francis et al. | Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination | |
| Webb et al. | Parana, a new Tacaribe complex virus from Paraguay | |
| Halbert et al. | The Increased Antigenicity of Shigella Paradysenteriae (Flexner) in Saline-in-Mineral-Oil Emulsion: Experiments in Mice and Rabbits | |
| Chen et al. | An evaluation of Pasteurella pestis fraction-1-specific antibody for the confirmation of plague infections | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| Meyer et al. | Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine | |
| Cutchins | A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles | |
| KR100202052B1 (en) | Detoxification method of bordetella pertussis toxin and the b. pertussis toxin detoxified by this method | |
| US4386065A (en) | Vaccine against EAE | |
| Guy | Acquired immunity in tuberculosis | |
| Gombosova et al. | Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis. | |
| Schmidt et al. | The complement-fixing antigen of rubella virus. | |
| Neff et al. | Smallpox vaccination by intradermal jet injection: 3. Evaluation in a well-vaccinated population | |
| Phair et al. | Influenza virus infection of the guinea pig: immune response and resistance | |
| Liebhaber et al. | Vaccination with RA 27/3 rubella vaccine: persistence of immunity and resistance to challenge after two years | |
| Metzgar et al. | Respiratory virus vaccines: II. Mycoplasma pneumoniae (Eaton agent) vaccines | |
| Kenyon et al. | Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture | |
| Anacker et al. | Immunological properties of Rickettsia rickettsii purified by zonal centrifugation | |
| Amies | Loss of immunogenic properties of vaccinia virus inactivated by formaldehyde |